Healthcare Policy

Overview

BakerHostetler’s Healthcare Policy team combines the efforts of experienced health law practitioners and policy professionals on behalf of clients seeking to resolve or avert public policy concerns through legislative or administrative action. We serve as partners and counselors for our clients as they navigate today’s complex and rapidly changing healthcare industry environment.

A Full Range of Capabilities

We approach our clients individually to craft a strategy for advocacy. This involves spending time with the client’s team to identify priorities, strengths, and issues of concern. Our team employs a strategy that engages members and staff from both sides of the political aisle and invites all interested parties to participate in crafting a legislative, regulatory, or administrative solution that both addresses the client’s concerns and adheres to sound principles of government policy. Policy achievements are accomplished through bipartisan advocacy efforts.

Our team develops strategic plans tailored to specific legislative and administrative goals. The team includes numerous former senior executive branch officials and former Capitol Hill staff members. Our extensive knowledge base and government contacts allow us to navigate the political waters in Washington, D.C., and beyond for healthcare industry clients interested in influencing the direction of change.

More »

Our team understands the core healthcare issues that drive our clients’ strategies, and we work seamlessly to provide health policy-focused services and solutions for a wide variety of clients, including:

  • Academic Medical Centers
  • Hospitals
  • Physician Groups
  • Home Health and Hospice Care
  • Dental Practices
  • Long-term Care Providers
  • Medical Device Companies
  • Pharmaceutical Manufacturers
  • Suppliers of Healthcare-related Goods
  • Trade Associations
  • Pharmacies
  • Dialysis Centers
  • Biologics and Cosmetics

Select Experience

  • Represent the nation’s leading pediatric hospital association in their efforts to develop special national network options in Medicaid policy for children with complex conditions; called the Advancing Care for Exceptional Kids Act of 2015 (HR 546/S 298), a bipartisan legislative initiative.
  • Represent hospitals in Texas and Washington State in challenging a CMS interpretation of the hospital-specific DSH reimbursement limit relative to the calculation of Medicaid shortfall.
  • Represent hospitals before Congress relating to Medicaid, CHIP, state-needed payments, and other government program reimbursement matters.
More »

Experience

  • Represent the nation’s leading pediatric hospital association in their efforts to develop special national network options in Medicaid policy for children with complex conditions; called the Advancing Care for Exceptional Kids Act of 2015 (HR 546/S 298), a bipartisan legislative initiative.
  • Represent hospitals in Texas and Washington State in challenging a CMS interpretation of the hospital-specific DSH reimbursement limit relative to the calculation of Medicaid shortfall.
  • Represent hospitals before Congress relating to Medicaid, CHIP, state-needed payments, and other government program reimbursement matters.
  • Routinely work with CMS, HRSA, CMM, and FDA to present client concerns, provide regulatory comments, and draft policy.
  • Advise pharmaceutical, medical device, and biologic manufacturers as well as private equity funds on recent FDA policy actions.
  • Represent clients in 340B and other reimbursement-related matters.

Recognition

  • Recognized as one of the top law firms for client service, BakerHostetler was named to the 2020 BTI Client Service 30 for the sixth consecutive year.

News

Publications

Blog

In The Blogs

Previous Next
Health Law Update
Capitol Hill Healthcare Update
December 9, 2019
YEAR-END LEGISLATIVE OVERDRIVE This week is crunch time on a host of legislative priorities, and various health-related provisions hang in the balance. Lawmakers and staff worked all weekend negotiating on legislation to fund the...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
December 2, 2019
HEALTH PROVISIONS FACE UNCERTAINTY AS CONGRESS RETURNS FOR BUSY DECEMBER Lawmakers return to Washington this week after the Thanksgiving holiday with only 18 days before the government runs out of money – and that’s not even the most...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
November 18, 2019
FDA NOMINATION HEARING DRIVES THE WEEK IN HEALTH POLICY President Trump’s nominee to lead the Food and Drug Administration, Dr. Stephen Hahn, will appear Wednesday before the Senate Health, Education, Labor and Pensions Committee for a...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
November 12, 2019
COMPREHENSIVE DRUG BILL STALLS WHILE HOUSE PUSHES SMALLER MEASURES House Democrats are planning to take up more narrow bills addressing prescription drug costs while their broad legislation is delayed as the Congressional Budget Office...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
October 28, 2019
DEMOCRATS PRESS FOR PRE-THANKSGIVING VOTE ON DRUG PRICING BILL The House Ways and Means Committee last week approved an amended version of legislation that would overhaul how Medicare and private insurers reimburse for prescription drugs...
Read More ->